<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03659227</url>
  </required_header>
  <id_info>
    <org_study_id>K180201J</org_study_id>
    <nct_id>NCT03659227</nct_id>
  </id_info>
  <brief_title>Drug Reactions Sampling (COLLECTIONTOXIDERMIES)</brief_title>
  <official_title>Adverse Cutaneous Drug Reactions Collection of Clinical Data and Biological Samples</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intro: Dermatology department of Henri Mondor Hospital (Creteil, France), is a reference
      center for toxic bullous diseases and severe cutaneous drug reactions (Stevens-Johnson
      syndrome (SJS), Lyell syndrome (toxic epidermal necrolysis (TEN)), generalized bullous fixed
      drug reactions, AGEP, DRESS, drug induced immunoglobulin A (IgA) bullous dermatosis, and
      erythema multiforme). In order to conduct clinical and biological research studies in drug
      reactions, it is necessary for the investigator's department to implement a collection of
      clinical data and biological samples.

      Hypothesis/Objective: To collect clinical data and cutaneous and biological samples for
      immunological, biological and genetic studies to improve knowledge about pathophysiology of
      drug reactions.

      Method: The following samples will be performed in addition to the routine practice samples:
      one skin punch biopsy (6mm); 43 mL of blood; blister fluid aspiration; oral and nose mucous
      membrane and skin eSWABs, stool samples.

      These samples will be stored in a dedicated biological sampling department (&quot;Platform of
      biological resources&quot;).

      Conclusion: The implementation of this collection should allow us to conduct
      pathophysiological studies about drug reactions.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 26, 2018</start_date>
  <completion_date type="Anticipated">September 25, 2028</completion_date>
  <primary_completion_date type="Anticipated">September 25, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Implementation of a clinical data and biological samples collection for cutaneous adverse reactions</measure>
    <time_frame>Day 0</time_frame>
    <description>Implementation of a clinical data and biological samples collection for cutaneous adverse reactions</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To conduct clinical and biological (immunological, histological, microbiological and genetic) studies in cutaneous adverse reactions.</measure>
    <time_frame>Day 0</time_frame>
    <description>To conduct clinical and biological (immunological, histological, microbiological and genetic) studies in cutaneous adverse reactions.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Stevens-Johnson Syndrome</condition>
  <condition>Lyell Syndrome</condition>
  <condition>Drug Reactions</condition>
  <condition>AGEP</condition>
  <condition>DRESS</condition>
  <condition>Bullous Dermatosis Caused by Drug Treatment (Disorder)</condition>
  <condition>Maculopapular Exanthem</condition>
  <condition>Erythema Multiforme</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      -  one skin punch biopsy

        -  blood (serum, cells, DNA and RNA studies);

        -  blister fluid aspiration;

        -  oral and nose mucous membrane and skin eSWABs ;

        -  stool samples.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with severe cutaneous adverse reactions (DRESS, AGEP, SJS/TEN, generalized bullous
        fixed drug eruption), drug-induced IgA linear dermatosis, maculo-papular exanthema,
        erythema multiforme.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient ≥ 18 y-old

          -  Severe cutaneous drug reaction (AGEP, DRESS, SJS/TEN, generalized bullous fixed drug
             eruption), drug-induced IgA bullous dermatosis, maculopapular exanthema, erythema
             multiforme

          -  Signed consent

          -  Social security affiliation

        Exclusion Criteria:

          -  Patients law protection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Saskia Oro, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>APHP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Saskia Oro, MD</last_name>
    <phone>0149812536</phone>
    <phone_ext>+33</phone_ext>
    <email>saskia.oro@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Laetitia Gregoire</last_name>
    <phone>0149814164</phone>
    <phone_ext>+33</phone_ext>
    <email>laetitia.gregoire@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Henri Mondor</name>
      <address>
        <city>Créteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Saskia Oro, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>September 3, 2018</study_first_submitted>
  <study_first_submitted_qc>September 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 6, 2018</study_first_posted>
  <last_update_submitted>January 18, 2019</last_update_submitted>
  <last_update_submitted_qc>January 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Drug reactions</keyword>
  <keyword>severe cutaneous adverse reactions (SCARs</keyword>
  <keyword>Stevens-Johnson syndrome</keyword>
  <keyword>Lyell Syndrome</keyword>
  <keyword>(generalized bullous) fixed drug reaction</keyword>
  <keyword>AGEP</keyword>
  <keyword>DRESS</keyword>
  <keyword>drug induced IgA bullous dermatosis</keyword>
  <keyword>maculopapular exanthema</keyword>
  <keyword>erythema multiforme</keyword>
  <keyword>sampling</keyword>
  <keyword>collection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stevens-Johnson Syndrome</mesh_term>
    <mesh_term>Erythema</mesh_term>
    <mesh_term>Skin Diseases</mesh_term>
    <mesh_term>Skin Diseases, Vesiculobullous</mesh_term>
    <mesh_term>Erythema Multiforme</mesh_term>
    <mesh_term>Drug Eruptions</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Drug-Related Side Effects and Adverse Reactions</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

